
Myriad and SOPHiA Partner on Liquid Biopsy Diagnostic Tool
Myriad Genetics, a leading company in molecular diagnostics and precision medicine, has launched a new global partnership with SOPHiA GENETICS, an AI-driven healthcare technology firm.

Myriad Genetics, a leading company in molecular diagnostics and precision medicine, has launched a new global partnership with SOPHiA GENETICS, an AI-driven healthcare technology firm.

Tethis S.p.A, a pioneer in standardized liquid biopsy platform development, and Sheba Medical Center, Israel’s largest medical center consistently ranked as a Top 10 World’s Best Hospital

SOPHiA GENETICS, a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking